Eligard 45mg and CPP

Drug TOLMAR, INC.
Total Payments
$100,953
Transactions
35
Doctors
3
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2017 $100,953 35 3

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $100,953 35 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
TOL2581A-CPP TOLMAR, INC. $100,953 3

Top Doctors Receiving Payments for Eligard 45mg and CPP

Doctor Specialty Location Total Records
Unknown — San Diego, CA $96,453 25
, MD Pediatric Endocrinology New Rochelle, NY $2,250 3
, MD Pediatric Endocrinology Washington, DC $1,200 4
, MD Pediatric Endocrinology Los Angeles, CA $1,050 3

Manufacturing Companies

Product Information

  • Type Drug
  • Total Payments $100,953
  • Total Doctors 3
  • Transactions 35

About Eligard 45mg and CPP

Eligard 45mg and CPP is a drug associated with $100,953 in payments to 3 healthcare providers, recorded across 35 transactions in the CMS Open Payments database. The primary manufacturer is TOLMAR, INC..

Payment data is available from 2017 to 2017. In 2017, $100,953 was paid across 35 transactions to 3 doctors.

The most common payment nature for Eligard 45mg and CPP is "Unspecified" ($100,953, 100.0% of total).

Eligard 45mg and CPP is associated with 1 research study, including "TOL2581A-CPP" ($100,953).